Virax Biolabs Statements
VR
Data from Virax Biolabs`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
31 Mar, 2022
Next reporting period:
27 Sep, 2022
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Virax Biolabs Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
0.434
0
1.3
0
1.734
205.9 %
0
-1.734
-205.9 %
0
-0.015
0
-0.001
0
-1.75
-204.3 %
0
—
0
-1.709
-209.3 %
0
-1.502
1.137
—
-100 %
100
—
0
—
—
0
0.108
0
0.459
0
0.567
-10.8 %
0
-0.567
12.1 %
0
-0.014
0
0.006
0
-0.575
14.5 %
0
—
0
-0.552
15.1 %
0
-0.486
1.137
0.124
784.4 %
100
0.133
107.6
-0.009
—
-7.6
0.12
97.1
0.515
415.8
0.635
64.8 %
512.9
-0.645
-73.5 %
-520.5
-0.029
-23.1
0
0.2
-0.673
-72.7 %
-543.5
—
0
-0.651
-89.5 %
-525.7
-0.572
1.137
0.014
—
100
—
0
—
—
0
0.059
417.9
0.327
2335.4
0.385
—
2753.3
-0.371
—
-2653.3
-0.018
-129.5
0
0.07
-0.39
—
-2782.7
—
0
-0.343
—
-2453.3
-0.03
11.374